LexDanaLexDanabeta
Inventor

Rong-lin ZHANG

Inventor
TW

Overview

3→
Patents
2024–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
B82YSpecific uses or applications of nanostructures25%
PatentTitleYear
12,496,355Method for treating a cancer and/or cancer metastasis202512,274,688Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain cancers or brain metastases202512,016,958Method for delivering an agent to posterior segment of an eye and uses thereof2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to NANO TARGETING & THERAPY BIOPHARMA INC (3)· patent assignee history
2024–2025Based in TW· patent location history
2025Patents assigned to SCINOPHARM TAIWAN LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NANO TARGETING & THERAPY BIOPHARMA INC32024–2025
SCINOPHARM TAIWAN LTD12025
Locations
LocationPatentsSpan
TW32024–2025